A/Prof Charles Malpas
Associate Professor Clinical Neuropsychology
Melbourne School of Psychological Sciences
318 Scholarly works
10 Projects
HIGHLIGHTS
2024
Research contracts (non-grants)
Cognitive Impairment in Multiple Sclerosis: Unravelling the Complexities of Clinical Practice
2022
Journal article
Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data
DOI: 10.1111/epi.173162022
Journal article
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy
DOI: 10.1093/brain/awab4172021
Journal article
Assessment of the DTI-ALPS Parameter Along the Perivascular Space in Older Adults at Risk of Dementia
DOI: 10.1111/jon.128372019
Research Grant
Biomarkers to Prevent Disability in Multiple Sclerosis
2019
Research grants (ARC, NHMRC, MRFF)
Evaluating the Effectiveness and Safety of Sodium Selenate as a Disease Modifying Treatment for Patients With Behavioural Variant Frontotemporal Dementia (Bvftd)
2019
Journal article
Multimodal structural neuroimaging markers of brain development and ADHD symptoms
DOI: 10.1176/appi.ajp.2018.18010034
RECENT SCHOLARLY WORKS
2026
Journal article
Bridging the gap: A symptom network analysis of depression, anxiety, and fatigue in multiple sclerosis
DOI: 10.1016/j.msard.2026.1071022026
Journal article
Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortium
DOI: 10.1016/j.msard.2026.1070962026
Journal article
Improved dietary control results in improvements in indices of white matter structure in adults with phenylketonuria: the ReDAPT study.
DOI: 10.1017/neu.2026.100782026
Journal article
Clarifications and response to "Validating plasma biomarkers for distinguishing neurodegenerative and psychiatric disorders" by Boccardi et al.
DOI: 10.1002/alz.713752026
Journal article
Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary Utility for Subacute Cognitive Monitoring after Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T-Cell Therapy
DOI: 10.1016/j.jtct.2025.11.0312026
Journal article
Cognitive Recovery Following Immune Effector Cell-Associated Neurotoxicity Syndrome in the First 6 Months after Chimeric Antigen Receptor T-Cell Therapy.
DOI: 10.1016/j.jtct.2026.03.0302026
Journal article
Biomarkers of neuroaxonal and astrocytic pathology in autoimmune encephalitis
DOI: 10.1016/j.bbi.2025.1062062026
Journal article
Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis
DOI: 10.1111/ene.70505